This partnership will take advantage of built-in cloud, mobile, social and artificial intelligence (AI) capabilities. These solutions — in addition to other products built on the Salesforce Marketing Cloud — will help life science companies drive patient recruitment, better manage clinical trials and, marketing activities, as well as and achieve other key activities objectives as the company brings new therapies to market.
“This Salesforce collaboration furthers our strategy of building our solutions on a foundation of intelligent, technology-standard platforms. Using this approach, as well as continuous updates provided by the platform providers, we can better focus on our areas of differentiation, which deliver the greatest value and benefit to our customers,” said Kevin Knightly, president, Information & Technology Solutions, QuintilesIMS. “We believe this alliance with Salesforce has transformative potential for the life sciences industry as it will better equip and enable our customers to meet the clinical-to-commercial challenges they face as they move healthcare forward.”
While terms of the agreement have not been disclosed, it is a multi-year venture that will operate on a global scale.